Clinical Trial Update: A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years [Phase 1]

View source ↗

Summary

A Phase 1 randomized, double-blind, placebo-controlled study assessing safety, tolerability, and pharmacokinetics of liraglutide in obese adolescents aged 12 to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 1 | Status: COMPLETED